Hjem › Bløddelssarkom › Utah
Bløddelssarkom kliniske forsøg i Utah
6 studier for Bløddelssarkom søger deltagere på steder i Utah.
Byer i Utah
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- GSK Investigational Site, West Valley City
RekruttererFase 1/2
Alle aldre · Alle køn · Opdateret 1. okt. 2026 · NCT07602777Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05732831A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors
- START Mountain Region, West Valley City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 4. maj 2026 · NCT06132503Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. apr. 2026 · NCT05297734A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Primary Children's Hospital, Salt Lake City
RekruttererFase 2
18 Months – 40 Years · Alle køn · Opdateret 12. aug. 2025 · NCT05135975Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.